Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation

Author:

Cristofori Patrizia,Crivellente Federica,Campagnola Mario,Pasini Anna Fratta,Garbin Ulisse,Rigoni Anna,Tosetti Maria,Turton John,Faustinelli Ivo,Cominacini Luciano

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Reference49 articles.

1. Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity;Van Amsterdam;Free Radic. Biol. Med.,1992

2. Presence of a modified low density lipoprotein in humans;Avogaro;Atherosclerosis,1988

3. Increased oxidazibility of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation;Babiy;Biochem. Pharmacol.,1992

4. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit;Boyd;Am. J. Pathol.,1989

5. Transgenic mouse models of lipoprotein metabolism and atherosclerosis;Breslow;Proc. Natl. Acad. Sci. USA,1993

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3